Maze Therapeutics CEO Jason V. Coloma disposes of 34,501 common shares worth $1.03 million

Maze Therapeutics, Inc.

Maze Therapeutics, Inc.

MAZE

0.00
  • Maze Therapeutics CEO Jason V. Coloma sold 34,501 shares of common stock on July 1.
  • Sales prices averaged about USD 29.95 to USD 30.44 per share.
  • Holdings fell to 23,337 shares in the Coloma 2021 Irrevocable Trust.
  • Holdings in the Coloma Family Trust ended at 287,171 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001676170-26-000014), on July 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.